Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
Fessler B.J..
Thrombotic syndromes and autoimmune diseases.
Rheum Dis Clin North Am., 23 (1997), pp. 461-479
[2.]
Bosch J.A., Clemente C., Sancho J., De Sobregrau R.C., Vilardell M..
Angiobehcet.
Rev Clin Esp., 194 (1994), pp. 629-635
[3.]
Leiba M., Sidi Y., Gur H., Leiba A., Ehrenfeld M..
Behçet disease and thrombophilia.
Ann Rheum Dis., 60 (2001), pp. 1081-1085
[4.]
Wahl D.G., Bounameaux H., De Moerloose P., Sarasin F.P..
Prophylactic antithrombotic therapy for patients with systemic lupus erythematosus with or without antiphospholipid antibodies.
Arch Intern Med., 160 (2000), pp. 2042-2048
[5.]
Khamashta M.A..
Primary prevention of thrombosis in subjects with positive antiphospholipid antibodies.
J Autoimmunity, 15 (2000), pp. 249-253
[6.]
Tolosa C..
Heparinas de bajo peso molecular en el síndrome antifosfolípido.
Rev Clin Esp., 202 (2002), pp. 17-21
Copyright © 2003. SEACV
